Seon-Hahn KIM, MD, PhD, FACS  Dr. Kim Seon Hahn is Professor and Consultant colorectal surgeon working at Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, as his new academic position appointed in Sep 2022. He had been Professor of Colorectal Division, Department of Surgery at Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea (2006-2022). He has been specifically interested in robotic and minimally invasive surgery and surgical anatomy in the colorectum during the past 30 years.   Prof. Kim has performed more than 3500 laparoscopic colon and rectal resections and over 1000 robotic rectal resections, mainly for cancer. He performed many live robotic and laparoscopic surgeries at various international congresses and at oversea hospitals. He was honored to give several orations such as; the ‘BJS Lecture’ at the 2015 Congress of European Society of Coloproctology in Dublin, the very first ‘Yasunobu Tsujinaka Memorial Oration’ at the 27th Annual Jagelman/37th Turnbull International Colorectal Symposium 2016 held in Florida, ‘The William Hugh Isbister Lecture’ at the 2019 Saudi-International Colorectal Diseases Forum in Riyadh, Saudi Arabia, and ‘Dr. Pradeep Chowbay Oration’ at Indian Association of Gastrointestinal Endosurgeons (IAGES) 2023 Midterm Conference in Bhopal, India.   Prof. Kim was the Founding President of Korean Association of Robotic Surgeons (KAROS, 2013-15) and the Chairman of the Korean Society of Endoscopic and Laparoscopic Surgeons (KSELS, 2014-16). He was awarded the Yeoh Ghim Seng Professor of Surgery by National University of Singapore (2008-14), and Dr. Anthony PC Yim Professorship in Minimally Invasive Surgery and Innovative Technology by Chinese University of Hong Kong (2011). He has been also invited as visiting professor/scholarship worldwide, including Cleveland Clinic Cleveland, OH, USA (2009), Royal Brisbane Hospital in Australia (2011), National Cheng Gong University in Taiwan (2012/2015), Kumamoto University in Japan (2013), Karolinska Institute Hospital in Stockholm, Sweden (2015/2017), and University of Western Sydney, Australia (2018-2024).

Dr. Mohamad NorTaufiq Nor Hashim is a scholar specializing primarily in Malay etymology, with further expertise in Malay language and culture, and the history of the Malay language. He obtained his PhD in Malay Linguistics from Universiti Sains Malaysia (USM) in 2022, after completing a Master of Arts in 2018 and a Bachelor of Arts (Honours) in 2017, also in Malay Linguistics at USM. His research explores the intersections of etymology, language, culture, and history, and he has published academic works in these areas. Together with lecturers from Universiti Tenaga Nasional (UNITEN), he co-developed Easy Malay, an interactive smart application designed to support Chinese learners in acquiring Malay vocabulary more effectively. His international academic experience includes serving as a Lecturer at Xi’an International Studies University (2020–2025), Yunnan University (2021–2023), and Tianjin Foreign Studies University (2019–2020), as well as a Visiting Lecturer at Yunnan Uniasia International Education Center (2023). Beyond academia, he also worked as Public Relations (PR) at the Malaysia Chamber of Commerce (MAYCHAM) Xi’an, China (2024–2025), where he contributed to strengthening bilateral and academic collaborations between Malaysia and China.

As a clinical pharmacist, researcher, and lecturer, my career has been driven by a commitment to improving patient care through translational research and education. With a strong foundation in managing critically ill patients, particularly in infectious diseases, I developed a deep interest in pharmacokinetics and its role in optimizing drug therapy. This passion led me to bridge clinical practice with research, ensuring that scientific advancements translate into real-world benefits for patients. Teaching became a natural extension of this mission, allowing me to shape future pharmacists and researchers with a focus on evidence-based practice and patient-centered care. Today, I continue to integrate clinical expertise, research innovation, and education to advance pharmacy practice and improve health outcomes.